F-Star Therapeutics, Inc.

FSTXCIK 0001566373 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Sep 9, 2022. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0024

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at F-Star Therapeutics, Inc.

Name	Roles	Filings
Arkowitz David	Director	2
Benz Edward Jr	Director	2
Bermingham Nessan	Director	2
Brady Todd C	Director	2
Klein Pamela M.	Director	2

Showing 6-10 of 10

Per pagePrevPage 2 of 2

All filings

25 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jan 9, 2023	Race Geoffrey Director	MExercise	3,937	$0.11	$433
Jun 22, 2022	Arkowitz David Director	Holdings only	-	-	-
Jun 22, 2022	Bermingham Nessan Director	Holdings only	-	-	-
Jun 22, 2022	Klein Pamela M. Director	Holdings only	-	-	-
Jun 22, 2022	Benz Edward Jr Director	Holdings only	-	-	-

Showing 11-15 of 25

Per pagePrevPage 3 of 5Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value